Source: bc.ctvnews.ca
2803 West 41st Avenue, Vancouver, British Columbia, Canada
Updated:
Source: bc.ctvnews.ca
Recent Interesting Reports
Ketogenesis scam, Las Vegas, Nevada, USA
1 week ago •reported by user-ffhdg745
Found phone # 18443789375. The company on my billing account was food and specialty store. Wouldn’t give address. Post office will not mail to p.o. #. But company will give you a RMA# to use. Spread this info out there. Their spam scum. Ketogenesis Keto+ACV PO box81827 Las Vegas Nevada 89180-1827
Called bank and blocked this.
Ring Scam, Yucca Avenue, Lancaster, CA, USA
3 weeks ago •reported by user-rzyzb777
Company on package says YOSHI DEALS
Unordered Package from Yoshi Deals Lancaster CA, Santa Maria, CA, USA
2 weeks ago •reported by user-cvcrc352
I have received two packages I did order. Shipper is Geathers Fottys., South Wolcott Avenue, Chicago, IL, USA
3 weeks ago •reported by user-zmgp7838
AuroMedics Pharma Methocarbamol Injection - recalled due to Particulate Matter presence, USA
3 weeks ago •source www.fda.gov
Recall notice
Administration of an injectable product that contains particulate matter may result in local irritation or swelling. If the particulate matter reaches the blood vessels or is injected intravascularly it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. To date, Eugia US LLC has not received any reports of adverse events related to this recall.
Methocarbamol injection USP 1000 mg/10 mL (100mg/mL), is used as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is packaged in 10 mL and packed as 25 (vials) X 04 (Printed E-Flute cartons) X 01 (Shipper) with NDC code as 55150-223-10. Eugia US LLC shipped the entire lot to wholesalers nationwide from Jan 12, 2024, through Jan 16, 2024.
The product can be identified by product name on carton and vial label and with lot number 3MC23011 and Exp. Date: Nov 2026 (NDC 55150-223-10) (See enclosed vial label). The product label is as shown in the image below.
Eugia US LLC (f/k/a AuroMedics Pharma LLC) is notifying its distributors by recall letters and is arranging for the return/replacement of all recalled products. Wholesalers, hospitals, pharmacies, institutions, and doctors with an existing inventory of the recalled product lot should discontinue use, stop distribution and quarantine the product immediately. If you have further distributed the recalled product lot, notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
If you are experiencing any harm after using this product it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist seek medical attention.
Company name: Eugia US LLC
Brand name: Eugia US LLC
Product recalled: Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial)
Reason of the recall: Device & Drug Safety – Presence of Particulate Matter
FDA Recall date: March 28, 2024
Source: www.fda.gov
A scam product received from, Charles Smith Avenue, Rancho Cucamonga, CA, USA
3 weeks ago •reported by user-rvxry173
Scam, Whittier, California, USA
2 weeks ago •reported by user-pctp8883
Everything about this Lighter …
I got a package I did not order, South Wolcott Avenue, Chicago, IL 60609, USA
1 week ago •reported by user-nmkrw681
Subgenix, East Greenwich, RI, USA
1 week ago •reported by user-hvrbn125
AvKARE, LLC Atovaquone Oral Suspension - recalled due to potential Bacillus cereus contamination, USA
3 weeks ago •source www.fda.gov
Recall notice
Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.
Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.
The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.
AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Â
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024
Source: www.fda.gov
Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com